Your browser doesn't support javascript.
loading
Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older.
Komaki, Yuri; Ozono, Yoshinori; Nakamura, Kenichi; Iwakiri, Hisayoshi; Hasuike, Satoru; Sueta, Mitsue; Miike, Tadashi; Yamamoto, Shojiro; Uto, Hirofumi; Kusumoto, Kazunori; Ochiai, Toshimasa; Kato, Junya; Komada, Naoto; Kuroki, Kazuo; Eto, Toshiharu; Shigehira, Masafumi; Hirono, Shuichi; Nagata, Kenji; Kawakami, Hiroshi.
Afiliação
  • Komaki Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Ozono Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Nakamura K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Iwakiri H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Hasuike S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Sueta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Miike T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Yamamoto S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Uto H; Department of Gastroenterology, Miyazaki Medical Center Hospital, Miyazaki, Japan.
  • Kusumoto K; Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan.
  • Ochiai T; Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan.
  • Kato J; Department of Internal Medicine, National Hospital Organization Miyakonojo Medical Center, Miyazaki, Japan.
  • Komada N; Department of Internal Medicine, National Hospital Organization Miyakonojo Medical Center, Miyazaki, Japan.
  • Kuroki K; Department of Internal Medicine, Kushima Municipal Hospital, Miyazaki, Japan.
  • Eto T; Department of Internal Medicine, Kushima Municipal Hospital, Miyazaki, Japan.
  • Shigehira M; Department of Internal Medicine, Shigehira Clinic, Miyazaki, Japan.
  • Hirono S; Department of Internal Medicine, Hirono Naika Clinic, Miyazaki, Japan.
  • Nagata K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Kawakami H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. hiropon@med.miyazaki-u.ac.jp.
BMC Gastroenterol ; 22(1): 210, 2022 Apr 28.
Article em En | MEDLINE | ID: mdl-35484503
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Hepatite C Crônica Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Hepatite C Crônica Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article